After a two-year hiatus from the US courts slowdown, nuclear verdicts in medmal have made their comeback with a vengeance, with jury awards doubling in size from pre-pandemic years, according to new claims data from TransRe.
In
Nuclear medmal verdicts: Is $50mn the new $25mn?
Frequency has rebounded, while severity has spiked beyond the pre-Covid-19 years.